• 0
MENU
Cart Details

Haemaprot 1.4mg Infusion

  • Home
  • Haemaprot 1.4mg Infusion

Product Informations: Haemaprot 1.4mg Infusion

In Bleeding Haemaprot 1.4mg Infusion helps control excessive bleeding in various conditions such as surgeries, heavy bleeding during periods, nosebleeds etc. It prevents damage to clots, enhances clot formation and helps prevent complications of excessive bleeding such as hemorrhage. It is given as an injection by a doctor or nurse and should not be self-administered.

Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Haemaprot 1.4mg Infusion is used to treat bleeding. It helps to prevent or reduce heavy bleeding after any surgery and in conditions such as heavy periods, dysfunctional uterine bleeding, or nosebleeds. Haemaprot 1.4mg Infusion must be administered under the supervision of a healthcare professional. Do not self-administer this medicine at home. You should not use it if you have any known allergies from this injection. It may cause injection site reactions such as pain, swelling, and redness in some people. Let your doctor know if they bother you. Additionally, inform your doctor if you have undergone any cardiac surgery or you are suffering from any liver disease.
Alcohol : CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Haemaprot 1.4mg Infusion. Please consult your doctor.

Pregnancy : SAFE IF PRESCRIBED

Haemaprot 1.4mg Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding : SAFE IF PRESCRIBED

Haemaprot 1.4mg Infusion is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving : NOT RELEVANT

Not relevant, as Haemaprot 1.4mg Infusion is intended for use in hospitalised patients.

Kidney : SAFE IF PRESCRIBED

Haemaprot 1.4mg Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Haemaprot 1.4mg Infusion may not be needed in these patients. Please consult your doctor.

Liver : CONSULT YOUR DOCTOR

There is limited information available on the use of Haemaprot 1.4mg Infusion in patients with liver disease. Please consult your doctor.

If you miss a dose of Haemaprot 1.4mg Infusion, skip it and continue with your normal schedule. Do not double the dose.

Chemical Class::Amino Acids, Peptides Analogues|Habit Forming::No|Therapeutic Class::BLOOD RELATED|Action Class::Antifibrinolytic
  • Q. Q. What Haemaprot 1.4mg Infusion is and what it is used for??
    Ans: Haemaprot 1.4mg Infusion belongs to a group of medicines called antifibrinolytics, i.e. medicines to prevent blood loss.
  • Q. Q. How is Haemaprot 1.4mg Infusion given??
    Ans: This injection will usually be given to you lying down by slow injection or infusion (through ‘a drip’) through a catheter into a larger vein in your body.
  • Q. Q. Can Haemaprot 1.4mg Infusion be given to children??
    Ans: This injection should be avoided in children since its safety and efficacy in children below the age of 18 years have not been established. Consult your doctor for more advice.
  • Q. Q. What other medications should be avoided while taking Haemaprot 1.4mg Infusion??
    Ans: It is advisable to avoid taking any other anti-fibrinolytic and antibiotics while taking Haemaprot 1.4mg Infusion. Inform your doctor before the start of the treatment if you are taking any of these.
  • Q. Q. What are some of the serious side-effects of Haemaprot 1.4mg Infusion??
    Ans: Some of the serious side-effects of this medicine are blood clots in the lungs, severe blood clotting disorder that results in tissue damage and bleeding, the inability of the blood to clot or coagulate normally, chest pain, and severe allergic shock (anaphylactic shock), which is potentially life-threatening. In such cases, your doctor will stop the treatment completely.

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More


All Substitutes Product.


Available options.

Same salt composition: Aprotinin (1.4mg)

Test Buy medical disposable face mask
to protect your loved ones